RedHill Biopharma Announces $6M Private Placement From OrbiMed Israel Partners Limited Partnership

RedHill Biopharma

today announced that it has entered into a definitive agreement with leading healthcare investor OrbiMed Israel Partners Limited Partnership, an affiliate of OrbiMed Advisors LLC, for the sale of RedHill's American Depository Shares and warrants in a private placement transactionor a total sum of $6.0 million.